SEARCH

SEARCH BY CITATION

References

  • 1
    Östman A, Hellberg C & Böhmer FD (2006) Protein-tyrosine phosphatases and cancer. Nat Rev Cancer6, 307320.
  • 2
    Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T et al. (2009) An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol19, 17881798.
  • 3
    Palka HL, Park M & Tonks NK (2003) Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem278, 57285735.
  • 4
    Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Böhmer F & Östman A (2000) Site selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein tyrosine phosphatase DEP-1. J Biol Chem275, 1621916226.
  • 5
    Iervolino A, Iuliano R, Trapasso F, Viglietto G, Melillo RM, Carlomagno F, Santoro M & Fusco A (2006) The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. Cancer Res66, 62806287.
  • 6
    Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO et al. (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol161, 793804.
  • 7
    Le Pera I, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G & Fusco A (2005) The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene24, 31873195.
  • 8
    Holsinger LJ, Ward K, Duffield B, Zachwieja J & Jallal B (2002) The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). Oncogene21, 70677076.
  • 9
    Sallee JL & Burridge K (2009) Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells. J Biol Chem284, 1499715006.
  • 10
    Keane MM, Lowrey GA, Ettenberg SA, Dayton MA & Lipkowitz S (1996) The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res56, 42364243.
  • 11
    Jandt E, Denner K, Kovalenko M, Östman A & Böhmer FD (2003) The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell–matrix adhesion. Oncogene22, 41754185.
  • 12
    Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B, Seto R, Infante L, Ishii H, Vecchione A et al. (2004) Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis25, 21072114.
  • 13
    Balavenkatraman KK, Jandt E, Friedrich K, Kautenburger T, Pool-Zobel BL, Östman A & Böhmer FD (2006) DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene25, 63196324.
  • 14
    Iuliano R, Trapasso F, Le Pera I, Schepis F, Samà I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G et al. (2003) An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Cancer Res63, 882886.
  • 15
    Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G & Fusco A (2000) Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol20, 92369246.
  • 16
    Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G et al. (2004) The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. J Biol Chem279, 2900429012.
  • 17
    Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L et al. (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet31, 295300.
  • 18
    Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L & Fusco A (2004) The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene23, 84328438.
  • 19
    Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR et al. (2007) DNA damage, homology-directed repair, and DNA methylation. PLoS Genet3, e110.
  • 20
    Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, Schackert HK, Görgens H, Hahn MM, Kamping EJ, Vreede L, Hoenselaar E, van der Looij E et al. (2010) Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer. Gastroenterology139, 22212224.
  • 21
    Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell136, 215233.
  • 22
    Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M et al. (2005) A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med353, 17931801.
  • 23
    Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E et al. (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene26, 75907595.
  • 24
    Garzon R, Calin GA & Croce CM (2009) MicroRNAs in cancer. Annu Rev Med60, 167179.
  • 25
    Calin GA & Croce CM (2006) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene25, 62026210.
  • 26
    Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J & Malumbres M (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell13, 496506.
  • 27
    Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR & de la Chapelle A (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA105, 72697274.
  • 28
    Hsu JB, Chiu CM, Hsu SD, Huang WY, Chien CH, Lee TY & Huang HD (2011) miRTar: an integrated system for identifying miRNA-target interactions in human. BMC Bioinformatics12, 300.
  • 29
    Ye W, Lv Q, Wong CK, Wu S, Fu C, Hua Z, Cai G, Li G, Yang BB & Zhang Y (2008) The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One3, e1719.
  • 30
    Rehmsmeier M, Steffen P, Höchsmann M & Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA10, 15071517.
  • 31
    Iuliano R, Raso C, Quintiero A, Pera IL, Pichiorri F, Palumbo T, Palmieri D, Pattarozzi A, Florio T, Viglietto G et al. (2009) The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization. J Biochem145, 377385.
  • 32
    Takahashi T, Takahashi K, Mernaugh RL, Tsuboi N, Liu H & Daniel TO (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood108, 12341242.
  • 33
    Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M & Takahashi T (2008) The tyrosine phosphatase CD148 interacts with p85 regulatory subunit of PI 3-kinase. Biochem J413, 193200.
  • 34
    Sacco F, Tinti M, Palma A, Ferrari E, Nardozza AP, Hooft van Huijsduijnen R, Takahashi T, Castagnoli L & Cesareni G (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J Biol Chem284, 2204822058.
  • 35
    Trapasso F, Drusco A, Costinean S, Alder H, Aqeilan RI, Iuliano R, Gaudio E, Raso C, Zanesi N, Croce CM et al. (2006) Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol25, 376382.
  • 36
    Den Hertog J, Östman A & Böhmer FD (2008) Protein tyrosine phosphatises: regulatory mechanisms. FEBS J275, 831847.
  • 37
    Karagyozov L, Godfrey R, Böhmer SA, Petermann A, Hölters S, Östman A & Böhmer FD (2008) The structure of the 5′-end of the protein-tyrosine phosphatase PTPRJ mRNA reveals a novel mechanism for translation attenuation. Nucleic Acids Res36, 44434453.
  • 38
    Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ et al. (2010) miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell140, 652665.
  • 39
    Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S, Lu WY, Zhang Y & Yang BB (2008) MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One3, e2420.
  • 40
    Pan YZ, Morris ME & Yu AM (2009) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol75, 13741379.
  • 41
    Brault L, Gasser C, Bracher F, Huber K, Knapp S & Schwaller J (2010) PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica95, 10041015.
  • 42
    Miguet L, Béchade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, Van Dorsselaer A, Mauvieux L & Sanglier-Cianferani S (2009) Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res8, 33463354.
  • 43
    Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE & Reifenberger G (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol20, 539550.
  • 44
    Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z et al. (2011) MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer129, 26212631.
  • 45
    Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, Lenhof HP & Meese E (2010) High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer10, 262.
  • 46
    Di Leva G & Croce CM (2010) Roles of small RNAs in tumor formation. Trends Mol Med16, 257267.
  • 47
    Leung AK & Sharp PA (2010) MicroRNA functions in stress responses. Mol Cell40, 205215.
  • 48
    Brunner PM, Heier PC, Mihaly-Bison J, Priglinger U, Binder BR & Prager GW (2011) Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells. Blood117, 41544161.
  • 49
    Petermann A, Haase D, Wetzel A, Balavenkatraman KK, Tenev T, Gührs KH, Friedrich S, Nakamura M, Mawrin C & Böhmer FD (2011) Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility. Brain Pathol21, 405418.
  • 50
    Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol3, 0034.